clinical trial · NCT01946386
A Vasoconstriction Study With LEO 90100
LEO Pharma·phase1·completed·n = 35
Psoriasis VulgarisLEO 90100 Aerosol, foamBetamethasone dipropionate in LEO 90100 Aerosol, foam, vehicleLEO 90100 Aerosol, foam, vehicleDaivobet® ointmentDermovate® creamSynalar® ointment
brief summary
The purpose of this study is to compare the pharmacodynamic activity of LEO 90100 with Dermovate® cream, Dovobet® ointment, betamethasone dipropionate in LEO90100 vehicle, Synalar® ointment and LEO 90100 vehicle using a human skin blanching test.
started
Sep 1, 2013
primary completion
Oct 1, 2013
completion
Oct 1, 2013
last updated
Feb 24, 2025
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol